Log in  First Connection?

Kidney TransplantationArchives

It never rains but pours: disseminated nocardiosis in a renal transplant patient from Nigeria – a case report

 Published on 04/02/2026 |  Original article (Full-text)  | Whitehead Thomas et al. | BMC Infectious Diseases 2025; 26(1): 117

Nocardia are ubiquitous Gram-positive, acid-fast bacteria found worldwide in soil and both fresh- and saltwater. The main route of infection is inhalation [1] but primary cutaneous infection can also occur following traumatic inoculation [2]. These environmental organisms were first described by French...

Continuous glucose monitoring in kidney transplant recipients: a narrative review

 Published on 28/01/2026 |  Original article (Full-text)  | Oweidat Khaled et al. | BMC Nephrology 2025; 27(1): 63

Continuous glucose monitoring (CGM) has become a transformative technology in diabetes management. Compared with traditional monitoring methods, which rely on intermittent blood or urine sampling only offering a fragmented view of glucose dynamics, CGM continuously tracks glucose levels in the interstitial...

Remimazolam tosylate vs. propofol: effects on anesthetic efficacy and renal function in living donor kidney transplantation

 Published on 21/01/2026 |  Original article (Full-text)  | Wu Jiaxin et al. | BMC Anesthesiology 2025; 25(1): 617

Propofol is the most widely used short-acting sedative in clinical practice. It inhibits histamine release in the hypothalamus by activating central gamma-aminobutyric acid A (GABA) receptors, blocks N-methyl-D-aspartate receptors, and modulates calcium influx to inhibit postsynaptic neuronal activity...

A population pharmacokinetic model for early follow-up dosing of tacrolimus in Tunisian kidney transplant recipients

 Published on 14/01/2026 |  Original article (Full-text)  | Amani Abderahmene et al. | Personalized Medicine 2025; 22(6): 455-465

Tacrolimus is the cornerstone of immunosuppressive therapy in kidney transplantation. However, it exhibits significant pharmacokinetic (PK) variability among patients. Therefore, Population Pharmacokinetic (PopPK) modeling is crucial for personalized tacrolimus treatment. While PopPK models have been...